Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy.
Neuberger M, Skladny J, Goly N, Wessels F, WEIß C, Egen L, Erben P, GROß-Weege M, Grüne B, Hartung F, Herrmann J, Honeck P, Jarczyk J, Kowalewski KF, Mühlbauer J, Nitschke K, Nientiedt M, Walach MT, Waldbillig F, Westhoff N, VON Hardenberg J, Kriegmair M, Worst TS, Nuhn P.
Neuberger M, et al. Among authors: hartung f.
Anticancer Res. 2022 Apr;42(4):1911-1918. doi: 10.21873/anticanres.15668.
Anticancer Res. 2022.
PMID: 35347010